|
CALL
|
$40,000
|
300
|
Q2 2025
Reduced 81.25%
|
|
|
PUT
|
$13,000
|
100
|
Q2 2025
Reduced 75.0%
|
|
|
CALL
|
$165,000
|
71.7K
|
Q2 2025
Added 180.08%
|
|
|
PUT
|
$616,000
|
267K
|
Q2 2025
Added 826.74%
|
|
|
CALL
|
$1.02 Million
|
70.5K
|
Q2 2025
Added 117.59%
|
|
|
PUT
|
$1.49 Million
|
104K
|
Q2 2025
Added 6.05%
|
|
|
CALL
|
$0
|
100
|
Q2 2025
New holding
|
|
Inovio Pharmaceuticals Inc
|
CALL
|
$396,000
|
195K
|
Q2 2025
Added 935.11%
|
|
Inovio Pharmaceuticals Inc
|
PUT
|
$2,000
|
1.4K
|
Q2 2025
New holding
|
|
|
CALL
|
$2.3 Million
|
45K
|
Q2 2025
Reduced 45.19%
|
|
|
PUT
|
$998,000
|
19.5K
|
Q2 2025
Added 56.0%
|
|
|
CALL
|
$165,000
|
20.3K
|
Q2 2025
Added 69.17%
|
|
|
CALL
|
$13,000
|
30.4K
|
Q2 2025
Added 29.36%
|
|
|
PUT
|
$1,000
|
200
|
Q2 2025
Reduced 66.67%
|
|
|
CALL
|
$739,000
|
5.7K
|
Q2 2025
Added 470.0%
|
|
|
PUT
|
$246,000
|
1.9K
|
Q2 2025
Added 58.33%
|
|
International Seaways Inc
|
CALL
|
$273,000
|
7.5K
|
Q2 2025
Reduced 7.41%
|
|
International Seaways Inc
|
PUT
|
$109,000
|
3K
|
Q2 2025
Reduced 11.76%
|
|
|
CALL
|
$103,000
|
2K
|
Q2 2025
Reduced 28.57%
|
|
|
PUT
|
$278,000
|
5.4K
|
Q2 2025
Added 575.0%
|
|
|
CALL
|
$35,000
|
4.8K
|
Q2 2025
Reduced 40.0%
|
|
|
PUT
|
$59,000
|
8K
|
Q2 2025
Reduced 23.81%
|
|
|
CALL
|
$37,000
|
5.1K
|
Q2 2025
Added 363.64%
|
|
|
PUT
|
$3,000
|
500
|
Q2 2025
Added 25.0%
|
|
|
PUT
|
$4,000
|
200
|
Q2 2025
Added 100.0%
|
|
|
CALL
|
$0
|
100
|
Q2 2025
New holding
|
|
|
CALL
|
$4.56 Million
|
139K
|
Q2 2025
Added 16.32%
|
|
|
PUT
|
$301,000
|
9.2K
|
Q2 2025
Reduced 14.02%
|
|
Innovex International Inc
|
CALL
|
$3,000
|
200
|
Q2 2025
New holding
|
|
Innovex International Inc
|
PUT
|
$15,000
|
1K
|
Q1 2025
Added 400.0%
|
|
|
CALL
|
$706,000
|
431K
|
Q2 2025
Reduced 20.68%
|
|
|
PUT
|
$488,000
|
298K
|
Q2 2025
Reduced 19.18%
|
|
|
CALL
|
$0
|
100
|
Q2 2025
New holding
|
|
Ionis Pharmaceuticals Inc
|
CALL
|
$3.34 Million
|
84.6K
|
Q2 2025
Added 115.82%
|
|
Ionis Pharmaceuticals Inc
|
PUT
|
$1.37 Million
|
34.6K
|
Q2 2025
Reduced 10.13%
|
|
Iovance Biotherapeutics Inc
|
CALL
|
$718,000
|
418K
|
Q2 2025
Reduced 11.21%
|
|
Iovance Biotherapeutics Inc
|
PUT
|
$415,000
|
242K
|
Q2 2025
Added 51.6%
|
|
|
CALL
|
$7.28 Million
|
156K
|
Q2 2025
Reduced 45.86%
|
|
|
PUT
|
$3.93 Million
|
83.9K
|
Q2 2025
Reduced 45.06%
|
|
Immunoprecise Antibodies LTD
|
CALL
|
$12,000
|
11.7K
|
Q2 2025
Reduced 58.66%
|
|
Immunoprecise Antibodies LTD
|
PUT
|
$0
|
100
|
Q1 2025
New holding
|
|
|
CALL
|
$328,000
|
2.5K
|
Q2 2025
Added 4.17%
|
|
|
PUT
|
$2.44 Million
|
18.6K
|
Q2 2025
Added 1966.67%
|
|
Interpublic Group Cos Inc
|
CALL
|
$401,000
|
16.4K
|
Q2 2025
Reduced 48.26%
|
|
Interpublic Group Cos Inc
|
PUT
|
$4,000
|
200
|
Q2 2025
Reduced 86.67%
|
|
|
CALL
|
$10,000
|
300
|
Q2 2025
Reduced 95.89%
|
|
|
PUT
|
$35,000
|
1K
|
Q2 2025
Reduced 75.0%
|
|
Renaissance Cap Greenwich Fd
|
CALL
|
$143,000
|
3.2K
|
Q2 2025
Added 1500.0%
|
|
|
CALL
|
$1.4 Million
|
791K
|
Q2 2025
Added 21.62%
|
|
|
PUT
|
$1.85 Million
|
1.05M
|
Q2 2025
Reduced 7.79%
|
|